Revvity, Inc. (RVTY)
128.80
-0.91
(-0.70%)
USD |
NYSE |
Aug 28, 16:00
128.78
-0.02
(-0.02%)
After-Hours: 20:00
Revvity Free Cash Flow : 558.11M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 558.11M |
| March 31, 2026 | 492.62M |
| December 31, 2025 | 506.94M |
| September 30, 2025 | 494.92M |
| June 30, 2025 | 500.49M |
| March 31, 2025 | 521.70M |
| December 31, 2024 | 541.65M |
| September 30, 2024 | -657.24M |
| June 30, 2024 | -838.64M |
| March 31, 2024 | -1.125B |
| December 31, 2023 | -1.212B |
| September 30, 2023 | -49.56M |
| June 30, 2023 | 110.55M |
| March 31, 2023 | 380.45M |
| December 31, 2022 | 594.18M |
| September 30, 2022 | 789.79M |
| June 30, 2022 | 974.92M |
| March 31, 2022 | 1.122B |
| December 31, 2021 | 1.325B |
| September 30, 2021 | 1.478B |
| June 30, 2021 | 1.380B |
| March 31, 2021 | 1.234B |
| December 31, 2020 | 814.67M |
| September 30, 2020 | 544.65M |
| June 30, 2020 | 443.56M |
| Date | Value |
|---|---|
| March 31, 2020 | 351.89M |
| December 31, 2019 | 282.14M |
| September 30, 2019 | 216.78M |
| June 30, 2019 | 199.05M |
| March 31, 2019 | 224.80M |
| December 31, 2018 | 217.78M |
| September 30, 2018 | 202.54M |
| June 30, 2018 | 177.80M |
| March 31, 2018 | 164.40M |
| December 31, 2017 | 249.36M |
| September 30, 2017 | 279.43M |
| June 30, 2017 | 296.88M |
| March 31, 2017 | 342.29M |
| December 31, 2016 | 318.91M |
| September 30, 2016 | 290.90M |
| June 30, 2016 | 278.84M |
| March 31, 2016 | 248.66M |
| December 31, 2015 | 257.47M |
| September 30, 2015 | 233.75M |
| June 30, 2015 | 235.90M |
| March 31, 2015 | 224.02M |
| December 31, 2014 | 252.52M |
| September 30, 2014 | 227.10M |
| June 30, 2014 | 211.32M |
| March 31, 2014 | 182.19M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agilent Technologies, Inc. | 1.267B |
| Thermo Fisher Scientific, Inc. | 7.318B |
| Danaher Corp. | 5.466B |
| Waters Corp. | 375.13M |
| Bio-Rad Laboratories, Inc. | 353.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 191.94M |
| Cash from Investing (Quarterly) | -3.505M |
| Cash from Financing (Quarterly) | -23.16M |
| Free Cash Flow Per Share (Quarterly) | 1.620 |
| Free Cash Flow to Equity (Quarterly) | 189.53M |
| Free Cash Flow to Firm (Quarterly) | 200.22M |
| Free Cash Flow Yield | 3.83% |